CNTA's logo.
Ticker Symbol: CNTA

Centessa Pharmaceuticals plc - ADR

$12.54 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: ADR CIK:0001847903

Company Profile

Centessa Pharmaceuticals plc aims to bring impactful new medicines to patients by combining the strengths of an asset-centric model with the benefits of scale and diversification typical of larger R&D organizations. The asset-centric model refers to a highly specialized, singular-focused company that is led by a team of well-recognized subject matter experts. Centessa wholly owns ten of these asset-centric companies. The companies’ programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology. Centessa’s asset-centric companies are overseen by the Centessa management team, which sets overall strategy and direction, provides leadership and expertise, and manages resource allocation and shared infrastructure.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 3, 2023 03:30 PM EST
Previous Close: $5.52
Change: -$0.10 ( -1.78%)
Days Range: $5.14 - $5.80
Beta: 1.11
52wk. High: $8.65
52wk. Low: $3.00
Ytd. Change 79.51%
50 Day Moving Average: $6.43
200 Day Moving Average: $5.85
Shares Outstanding: 97402945

Valuation

Market Cap: 53.8B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A